Log in to save to my catalogue

Glypican-3 as a Useful Diagnostic Marker That Distinguishes Hepatocellular Carcinoma From Benign Hep...

Glypican-3 as a Useful Diagnostic Marker That Distinguishes Hepatocellular Carcinoma From Benign Hep...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_5858_132_11_1723

Glypican-3 as a Useful Diagnostic Marker That Distinguishes Hepatocellular Carcinoma From Benign Hepatocellular Mass Lesions

About this item

Full title

Glypican-3 as a Useful Diagnostic Marker That Distinguishes Hepatocellular Carcinoma From Benign Hepatocellular Mass Lesions

Journal title

Archives of pathology & laboratory medicine (1976), 2008-11, Vol.132 (11), p.1723-1728

Language

English

Formats

More information

Scope and Contents

Contents

Context.—Histopathologic distinction between hepatocellular carcinoma (HCC) and benign hepatocellular mass lesions, particularly hepatocellular adenoma, can sometimes be challenging. The currently available ancillary tools are suboptimal in terms of sensitivity and specificity.
Objective.—To further characterize the diagnostic value of glypican-...

Alternative Titles

Full title

Glypican-3 as a Useful Diagnostic Marker That Distinguishes Hepatocellular Carcinoma From Benign Hepatocellular Mass Lesions

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_crossref_primary_10_5858_132_11_1723

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_5858_132_11_1723

Other Identifiers

ISSN

0003-9985

E-ISSN

1543-2165

DOI

10.5858/132.11.1723

How to access this item